FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004429204> ?p ?o ?g. }

• W2004429204 endingPage "3394" @default.
• W2004429204 startingPage "3389" @default.
• W2004429204 abstract "Concern arose in 2010 that reactogenicity, particularly febrile seizures, to influenza A/H1N1-containing 2010–2011 trivalent seasonal inactivated influenza vaccine (TIV) could occur in young children who had been previously immunized and/or infected with the pandemic strain. We conducted a pre-season study of 2010–2011 TIV safety and immunogenicity in children 12–59 months of age to inform public health decision making. Children immunized with 1 or 2 doses of the pandemic vaccine, with or without the 2009–10 TIV, received 1 or 2 doses of 2010–11 TIV in an observational, multicentre Canadian study. Standard safety monitoring was enhanced by a telephone call at ∼24 h post-TIV when adverse events were expected to peak. Summary safety reports were rapidly reported to public health before the launch of public programs. TIV immunogenicity was assessed day 0, and 21 days after final vaccination. Clinical Trials Registration NCT01180621. Among 207 children, a general adverse event was reported by 60.9% of children post-dose one and by 58.3% post-dose two. Only severe fever (>38.5 °C) was more common in two-dose compared to one dose recipients (16.7%, n = 4 v. 1.0%, n = 2). At baseline 99.0% of participants had A/H1N1 hemagglutinin inhibition (HAI) titers ≥10, and 85.5% had a protective titer of ≥40 (95% CI 80.0, 90.0). Baseline geometric mean titers (GMT) were higher in recipients of a 2-dose schedule of pandemic vaccine compared to one-dose recipients: 153.1 (95% CI 126.2, 185.7) v. 78.8 ((58.1, 106.8, p < 0.001). At 21 days, all regulatory criteria for influenza vaccine immunogenicity were exceeded for A/H1N1 and H3N2, but responses to the B antigen were poor. No correlations between reactogenicity and either baseline high influenza titers or serologic response to revaccination were evident. Infants and toddlers who received AS03-adjuvanted A/H1N1 2009 vaccine up to 11 months earlier retained high titers in the subsequent season but re-exposure to A/H1N1 2009 antigen in TIV resulted in no unusual adverse effects and 100% were sero-protected for A/H1N1 after receipt of the 2010–11 TIV." @default.
• W2004429204 created "2016-06-24" @default.
• W2004429204 creator A5003004507 @default.
• W2004429204 creator A5021564602 @default.
• W2004429204 creator A5026702655 @default.
• W2004429204 creator A5038805449 @default.
• W2004429204 creator A5041854540 @default.
• W2004429204 creator A5042366190 @default.
• W2004429204 creator A5043472782 @default.
• W2004429204 creator A5045040015 @default.
• W2004429204 creator A5050808267 @default.
• W2004429204 creator A5064405479 @default.
• W2004429204 creator A5083645506 @default.
• W2004429204 creator A5086060594 @default.
• W2004429204 creator A5088217043 @default.
• W2004429204 creator A5088658252 @default.
• W2004429204 date "2012-05-01" @default.
• W2004429204 modified "2023-09-24" @default.
• W2004429204 title "Safety and immunogenicity of 2010–2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12–59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study" @default.
• W2004429204 cites W1553996414 @default.
• W2004429204 cites W1588310307 @default.
• W2004429204 cites W1982310373 @default.
• W2004429204 cites W1983669467 @default.
• W2004429204 cites W2034712058 @default.
• W2004429204 cites W2080484488 @default.
• W2004429204 cites W2080864485 @default.
• W2004429204 cites W2090326173 @default.
• W2004429204 cites W2144025889 @default.
• W2004429204 cites W2316990765 @default.
• W2004429204 doi "https://doi.org/10.1016/j.vaccine.2012.03.046" @default.
• W2004429204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22469860" @default.
• W2004429204 hasPublicationYear "2012" @default.
• W2004429204 type Work @default.
• W2004429204 sameAs 2004429204 @default.
• W2004429204 citedByCount "16" @default.
• W2004429204 countsByYear W20044292042012 @default.
• W2004429204 countsByYear W20044292042013 @default.
• W2004429204 countsByYear W20044292042014 @default.
• W2004429204 countsByYear W20044292042015 @default.
• W2004429204 countsByYear W20044292042016 @default.
• W2004429204 countsByYear W20044292042019 @default.
• W2004429204 crossrefType "journal-article" @default.
• W2004429204 hasAuthorship W2004429204A5003004507 @default.
• W2004429204 hasAuthorship W2004429204A5021564602 @default.
• W2004429204 hasAuthorship W2004429204A5026702655 @default.
• W2004429204 hasAuthorship W2004429204A5038805449 @default.
• W2004429204 hasAuthorship W2004429204A5041854540 @default.
• W2004429204 hasAuthorship W2004429204A5042366190 @default.
• W2004429204 hasAuthorship W2004429204A5043472782 @default.
• W2004429204 hasAuthorship W2004429204A5045040015 @default.
• W2004429204 hasAuthorship W2004429204A5050808267 @default.
• W2004429204 hasAuthorship W2004429204A5064405479 @default.
• W2004429204 hasAuthorship W2004429204A5083645506 @default.
• W2004429204 hasAuthorship W2004429204A5086060594 @default.
• W2004429204 hasAuthorship W2004429204A5088217043 @default.
• W2004429204 hasAuthorship W2004429204A5088658252 @default.
• W2004429204 hasConcept C126322002 @default.
• W2004429204 hasConcept C138816342 @default.
• W2004429204 hasConcept C159047783 @default.
• W2004429204 hasConcept C159110408 @default.
• W2004429204 hasConcept C159654299 @default.
• W2004429204 hasConcept C187212893 @default.
• W2004429204 hasConcept C197934379 @default.
• W2004429204 hasConcept C203014093 @default.
• W2004429204 hasConcept C22070199 @default.
• W2004429204 hasConcept C2522874641 @default.
• W2004429204 hasConcept C2777704310 @default.
• W2004429204 hasConcept C2779134260 @default.
• W2004429204 hasConcept C2780689484 @default.
• W2004429204 hasConcept C2780801004 @default.
• W2004429204 hasConcept C2780868878 @default.
• W2004429204 hasConcept C2909469553 @default.
• W2004429204 hasConcept C3008058167 @default.
• W2004429204 hasConcept C32611913 @default.
• W2004429204 hasConcept C524204448 @default.
• W2004429204 hasConcept C71924100 @default.
• W2004429204 hasConcept C89623803 @default.
• W2004429204 hasConceptScore W2004429204C126322002 @default.
• W2004429204 hasConceptScore W2004429204C138816342 @default.
• W2004429204 hasConceptScore W2004429204C159047783 @default.
• W2004429204 hasConceptScore W2004429204C159110408 @default.
• W2004429204 hasConceptScore W2004429204C159654299 @default.
• W2004429204 hasConceptScore W2004429204C187212893 @default.
• W2004429204 hasConceptScore W2004429204C197934379 @default.
• W2004429204 hasConceptScore W2004429204C203014093 @default.
• W2004429204 hasConceptScore W2004429204C22070199 @default.
• W2004429204 hasConceptScore W2004429204C2522874641 @default.
• W2004429204 hasConceptScore W2004429204C2777704310 @default.
• W2004429204 hasConceptScore W2004429204C2779134260 @default.
• W2004429204 hasConceptScore W2004429204C2780689484 @default.
• W2004429204 hasConceptScore W2004429204C2780801004 @default.
• W2004429204 hasConceptScore W2004429204C2780868878 @default.
• W2004429204 hasConceptScore W2004429204C2909469553 @default.
• W2004429204 hasConceptScore W2004429204C3008058167 @default.
• W2004429204 hasConceptScore W2004429204C32611913 @default.
• W2004429204 hasConceptScore W2004429204C524204448 @default.
• W2004429204 hasConceptScore W2004429204C71924100 @default.
• W2004429204 hasConceptScore W2004429204C89623803 @default.

• next